AAN 2021 | Gender-specific challenges for women with epilepsy
Kimford Meador, MD, FAAN, Stanford University, Stanford, CA, talks on the gender-specific challenges faced by women with epilepsy. The risks associated with pregnancy for women with epilepsy are well recognized but there are other common gender-specific problems, including catamenial epilepsy, where seizure frequency varies with hormonal pattern fluctuations. Dr Meador also discusses the impacts epilepsy and its treatments can have on contraceptive efficacy and bone density. This interview took place during the American Academy of Neurology (AAN) 2021 Annual Meeting.
Disclosures
Grants: NIH/NINDS 2U01-NS038455-11A1. Meador (Multi-PI). “Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs.”*
NIH/NINDS R01NS088748-01. Drane (PI). “Dissecting the Cognitive Roles of Hippocampus & Other Temporal Lobe Structures.” Role: Co-I.
Medtronics. Halpern (PI). “Stereotactic Laser Ablation for Temporal Lobe Epilepsy (SLATE).” Role: Co-I.
Eisai Inc. Razavi (PI). “Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures.” Role: Co-I.
Sunovion Pharma. Meador (PI). “Cognitive and Behavioral Effects of Eslicarbazepine Acetate and Carbamazepine in Healthy Adults.”
Consultant (no personal income): Epilepsy Consortium (funds paid to my university)* for Eisai, GW Pharmaceuticals, Medtronics, NeuroPace, Novartis, Supernus, Upsher Smith Labs, UCB Pharma, and Vivus Pharm.
Other: Clinical income: EEG procedures and patient care*
*Items with asterisk involve income > $10,000 for recent years.
